| Patient | Thomas Jefferson |
|---|---|
| Date of birth | 1979-04-13 |
| Identifiers | MRN HR-EN005-SYN; SSN (made up) 000-05-2276 |
| Document date | 2026-07-16 |
| Author | Nathaniel Beaumont-Ruiz, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Periodic adult preventive visit. [S]
Mr. Jefferson is a 47-year-old cabinet secretary with episodic migraine without aura on propranolol prevention and an old right wrist injury, who comes for his yearly preventive visit four weeks after his six-week review. He has had one migraine attack in the past four weeks, treated with sumatriptan and naproxen and gone within two hours. He has taken propranolol 120 mg each evening for four weeks without dizziness, breathlessness or low mood, and he notices cold fingers on cool mornings. His diary shows acute medicine on one day this month. He has had no tetanus booster for more than ten years and has never had a colon cancer screening test. [S]
| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 47 |
| Migraine | One attack in four weeks; acute medicine on one day |
| Propranolol | 120 mg each evening for four weeks; cold fingers on cool mornings |
| Mood | PHQ-2 0 |
| Medicines | Propranolol ER 120 mg each evening; sumatriptan 100 mg with naproxen 500 mg as needed; metoclopramide 10 mg as needed |
Health risk assessment. Completed by the patient on paper in the waiting room and reviewed with him by Dr. Beaumont-Ruiz. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Good, and much better than in the spring |
| Psychosocial | Demanding work he enjoys; close friends; misses his daughters, who live in Virginia |
| Alcohol | A glass of wine with dinner two or three times a week; AUDIT-C 3 at intake |
| Tobacco | Never |
| Physical activity | Walks most days for 30 to 60 minutes |
| Nutrition | Vegetables, fruit and dairy most days, with modest amounts of meat; no longer skips lunch on working days |
| Sleep | Six and a half to seven hours, with a fixed wake time |
| Safety at home | Feels safe; no firearms at home |
| Road safety | Wears a seat belt |
| Activities of daily living | Independent |
| Hearing and vision | No hearing difficulty; uses reading glasses for small print in the evening |
| Oral health | Dental visit last year |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, weight loss or night sweats |
| Eyes | Negative | No vision change; no visual aura |
| Ears, nose, mouth, and throat | Negative | Cold resolved; no hearing loss |
| Cardiovascular | Negative | No chest pain, palpitations or light-headedness |
| Respiratory | Negative | No wheeze or breathlessness on propranolol |
| Gastrointestinal | Negative | No abdominal pain, change in bowel habit or blood in the stool |
| Genitourinary | Negative | No urinary symptoms |
| Musculoskeletal | Positive | Right wrist stiff after long writing; better with the splint |
| Integumentary | Negative | No rash |
| Neurological | Positive | One migraine attack this month; no weakness, numbness or new headache pattern |
| Psychiatric | Negative | Mood good; PHQ-2 0 |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen 500 mg oral tablet, one tablet with food at the start of a headache, may repeat once after 12 hours; no more than two days a week | One tablet at headache onset, may repeat once after 12 hours; no more than two days a week | Oral route | 2026-05-07 | active | S |
| Metoclopramide 10 mg oral tablet, one tablet with the naproxen when a headache brings nausea; no more than two days a week | One tablet with the acute medicine when nausea is present, no more than once a day | Oral route | 2026-05-07 | active | S |
| Sumatriptan 100 mg oral tablet, one tablet with naproxen early in a migraine attack, may repeat once after 2 hours; no more than two tablets a day and no more than nine days a month | One tablet at attack onset with naproxen, may repeat once after 2 hours; up to 200 mg a day | Oral route | 2026-05-21 | active | S |
| Propranolol extended-release 80 mg oral capsule, one capsule each evening, for migraine prevention | One capsule each evening | Oral route | 2026-05-21 to 2026-06-18 | completed | S |
| Propranolol extended-release 120 mg oral capsule, one capsule each evening, for migraine prevention | One capsule each evening | Oral route | 2026-06-18 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-16 | Body height | 189 | cm | S |
| 2026-07-16 | Body weight | 76.4 | kg | S |
| 2026-07-16 | Body mass index (BMI) [Ratio] | 21.4 | kg/m2 | S |
| 2026-07-16 | Systolic blood pressure | 114 | mm[Hg] | S |
| 2026-07-16 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-07-16 | Heart rate | 58 | /min | S |
| 2026-07-16 | Respiratory rate | 14 | /min | S |
| 2026-07-16 | Body temperature | 36.6 | Cel | S |
| 2026-07-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-16 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-07-16 | Cholesterol [Mass/volume] in Serum or Plasma | 182 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-07-16 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 64 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-07-16 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 102 | mg/dL | <=99 mg/dL | High | S |
| 2026-07-16 | Triglyceride [Mass/volume] in Serum or Plasma | 80 | mg/dL | <=149 mg/dL | Normal | S |
Vital signs recorded on 2026-07-16; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well; weight 76.4 kg, BMI 21.4; blood pressure 114/72; pulse 58 and regular |
| Eyes | Pupils equal and reactive; fundi with sharp discs |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm; no murmur; pulses normal |
| Respiratory | Clear to auscultation |
| Abdomen | Soft and non-tender |
| Musculoskeletal | Right wrist with reduced flexion and extension, a prominent ulnar head, and swelling of the finger joints; grip weaker on the right |
| Skin | Fingers cool, with normal color and capillary refill |
| Neurological | Normal |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Recurrent disabling headaches since early adulthood, in bouts lasting days to weeks, now in the seventh day of a bout; under evaluation, with a two-week headache diary and a headache medicine consultation; no red flags | resolved | confirmed | R51.9 | S — Synthetic presenting problem anchored to his documented periodical headaches; superseded when the consultation confirmed migraine without aura. |
| Migraine without aura, episodic, with bouts of near-daily attacks lasting two to three weeks; ICHD-3 criteria met in a two-week diary; synthetic modern diagnosis linked to his documented periodical headaches, which historians have usually but not unanimously called migraine | active | confirmed | G43.009 | S — Synthetic modern diagnosis made at the consultation; the historical diagnosis is disputed (CLM-0013), so this is not a claim about his real diagnosis. |
| Stiffness and weakness of the right wrist and hand after a dislocation that healed out of place in early middle age; writing is slow and painful after about an hour | active | confirmed | M25.631 | S — Synthetic modern coding of the documented badly healed right wrist dislocation. |
| Common cold with nasal congestion and facial pressure, without bacterial sinusitis, early in propranolol prevention; resolved | resolved | confirmed | J00 | S — Synthetic acute illness; not a historical claim. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure screening | Completed today | 114/72 mmHg |
| Lipid screening and cardiovascular risk | Completed today | Total cholesterol 182, HDL 64, LDL 102, triglycerides 80 mg/dL; 10-year risk low; statin not indicated |
| Diabetes screening | Not indicated | Recommended at 35 to 70 for adults with overweight or obesity; BMI 21.4 |
| Colorectal cancer screening | Ordered | Age 45 to 75; FIT kit given today |
| HIV screening | Ordered | Once for all adults; drawn today with his agreement |
| Hepatitis C screening | Ordered | Once for all adults; drawn today |
| Hepatitis B screening | Ordered | Triple panel once for all adults; drawn today |
| Depression screening | Completed today | PHQ-2 0 |
| Unhealthy alcohol use | Up to date | AUDIT-C 3 at intake, below the threshold for men |
| Tobacco use | Not indicated | Never used tobacco |
| Prostate cancer screening | Not indicated | Shared decision-making begins at 55 |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap given today; last booster more than ten years ago |
| Hepatitis B vaccine | Completed today | First of two HepB-CpG doses today; second in one month |
| Influenza and COVID-19 vaccines | Not indicated | Not yet in season; to be given in the autumn |
| Zoster vaccine | Not indicated | Recommended from age 50 |
Immunizations given today: Tdap vaccine; last tetanus booster more than ten years ago; Hepatitis B vaccine (HepB-CpG), first of two doses [S]
Guideline basis: The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022); Colorectal Cancer: Screening (2021); Adult Immunization Schedule by Age (2026)
Follow-up: Three-month review in four weeks. FIT kit returned by mail. HIV, hepatitis C and hepatitis B results by phone. Second hepatitis B vaccine dose in one month. Next preventive visit in one year. Next scheduled visit 2026-08-13: three-month review: response to prevention, disability, acute medicine use and the plan ahead. [S]
Voluntary advance care planning discussion of about 18 minutes, with his consent. He named a health care agent, a close friend, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is being able to think, read and write, and to keep his independence. He chose not to record specific treatment preferences today. The plan will be revisited yearly or after any serious illness. [S]